Sfoglia per Autore
Two more inv(16) acute myeloid leukemia cases with infrequent CBFβ-MYH11 fusion transcript: Clinical and molecular findings [4]
2002 Martinelli G.; Ottaviani E.; Buonomici S.; Isidori A.; Malagola M.; Piccaluga P.; Baccarani M.
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC
2003 Bianchini M.; Ottaviani E.; Grafone T.; Giannini B.; Soverini S.; Terragna C.; Amabile M.; Piccaluga P.P.; Malagola M.; Rondoni M.; Bosi C.; Baccarani M.; Martinelli G.
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8]
2003 Martinelli G.; Buonamici S.; Visani G.; Malagola M.; Piccaluga P.P.; Isidori A.; Bosi C.; Bonifazi F.; Soverini S.; Terragna C.; Amabile M.; Giannini B.; Baccarani M.; Guerrasio A.; Pilatrino C.; Cilloni D.; Gottardi E.; Saglio G.
Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma
2004 ASCANI S; WENT P; LIBERATI AM; PICCALUGA PP; ZINZANI P.; PILERI SA
Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission
2004 MALAGOLA M; MARTINELLI G.; RONDONI M; OTTAVIANI E; PICCALUGA PP; RICCI P; VISANI G; BACCARANI M.
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?
2004 VISANI G; ISIDORI A; GRAFONE T; TOSI P; SANTINI V; MALAGOLA M; MARTINELLI G.; PICCALUGA PP; GRAZIEV D; OTTAVIANI E; SPARAVENTI G; TURA S.
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia
2004 PICCALUGA PP; MALAGOLA M; RONDONI M; AMABILE M; PAOLINI S; SOVERINI S; GAITANI S; VISANI G; BACCARANI M.; MARTINELLI G
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
2004 MARTINELLI G; RONDONI M; BUONAMICI S; OTTAVIANI E; PICCALUGA PP; MALAGOLA M; BACCARANI M.
Prompt resolution of nasal aspergillosis with intranasal instillation of liposomal amphotericin-B (amBisome) and granulocyte transfusions
2004 PICCALUGA PP; RICCI P; MARTINELLI G.; MALAGOLA M; RONDONI M; VISANI G.
Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?
2004 Visani G; Malagola M; Piccaluga PP; Isidori A.
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts
2004 Martinelli, Giovanni; Ottaviani, Emanuela; Buonamici, Silvia; Isidori, Alessandro; Borsaru, Gabriela; Visani, Giuseppe; Piccaluga, Pier Paolo; Malagola, Michele; Testoni, Nicoletta; Rondoni, Michela; Nucifora, Giuseppina; Tura, Sante; Baccarani, Michele
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome
2004 ASCANI S; SABATTINI E; AGOSTINELLI C; PICCALUGA PP; ZINZANI P.; PILERI SA
Identification of outcome predictors in diffuse large B-cell lymphoma. of homogeneously treated de novo nodal tumours on tissue micro-arrays.
2004 Pileri S.A.; Dirnhofer S.; Sabattini E.; Piccaluga P.P.; Bacci F.; Agostinelli C.; Bodega L.; Orduz R.; Falini B.; Zinzani P.L.
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation.
2004 PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BIANCHINI M; VIGNA E; BOSI C; GAITANI S; VISANI G; BACCARANI M.
Babesia infection in Italy
2004 PICCALUGA PP; POLETTI G; MARTINELLI G.; GHERLINZONI F
Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report.
2004 Mele A; Sparaventi G; Guiducci B; Nicolini G; d'Adamo F; Leopardi G; Delfini C; Piccaluga P; Visani G.
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.
2004 PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M.; MARTINELLI G.
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients.
2004 PICCALUGA PP; MARTINELLI G; RONDONI M; MALAGOLA M; GAITANI S; VISANI G; BACCARANI M.
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia
2004 PICCALUGA PP; LUATTI S; ASCANI S; BIANCHINI M; MALAGOLA M; RONDONI M; GAITANI S; TESTONI N.; PILERI SA; BACCARANI M; MARTINELLI G; VISANI G
Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly
2004 Piccaluga, Pier Paolo; Martinelli, Giovanni; Rondoni, Michela; Malagola, Michele; Ronconi, Sonia; Visani, Giuseppe; Baccarani, Michele
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Two more inv(16) acute myeloid leukemia cases with infrequent CBFβ-MYH11 fusion transcript: Clinical and molecular findings [4] | Martinelli G.; Ottaviani E.; Buonomici S.; Isidori A.; Malagola M.; Piccaluga P.; Baccarani M. | 2002-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC | Bianchini M.; Ottaviani E.; Grafone T.; Giannini B.; Soverini S.; Terragna C.; Amabile M.; Piccal...uga P.P.; Malagola M.; Rondoni M.; Bosi C.; Baccarani M.; Martinelli G. | 2003-01-01 | CLINICAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] | Martinelli G.; Buonamici S.; Visani G.; Malagola M.; Piccaluga P.P.; Isidori A.; Bosi C.; Bonifaz...i F.; Soverini S.; Terragna C.; Amabile M.; Giannini B.; Baccarani M.; Guerrasio A.; Pilatrino C.; Cilloni D.; Gottardi E.; Saglio G. | 2003-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma | ASCANI S; WENT P; LIBERATI AM; PICCALUGA PP; ZINZANI P.; PILERI SA | 2004-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission | MALAGOLA M; MARTINELLI G.; RONDONI M; OTTAVIANI E; PICCALUGA PP; RICCI P; VISANI G; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | ECR25.full.pdf |
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response? | VISANI G; ISIDORI A; GRAFONE T; TOSI P; SANTINI V; MALAGOLA M; MARTINELLI G.; PICCALUGA PP; GRAZI...EV D; OTTAVIANI E; SPARAVENTI G; TURA S. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia | PICCALUGA PP; MALAGOLA M; RONDONI M; AMABILE M; PAOLINI S; SOVERINI S; GAITANI S; VISANI G; BACCA...RANI M.; MARTINELLI G | 2004-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely. | MARTINELLI G; RONDONI M; BUONAMICI S; OTTAVIANI E; PICCALUGA PP; MALAGOLA M; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Prompt resolution of nasal aspergillosis with intranasal instillation of liposomal amphotericin-B (amBisome) and granulocyte transfusions | PICCALUGA PP; RICCI P; MARTINELLI G.; MALAGOLA M; RONDONI M; VISANI G. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy? | Visani G; Malagola M; Piccaluga PP; Isidori A. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts | Martinelli, Giovanni; Ottaviani, Emanuela; Buonamici, Silvia; Isidori, Alessandro; Borsaru, Gabri...ela; Visani, Giuseppe; Piccaluga, Pier Paolo; Malagola, Michele; Testoni, Nicoletta; Rondoni, Michela; Nucifora, Giuseppina; Tura, Sante; Baccarani, Michele | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 1221.full.pdf |
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome | ASCANI S; SABATTINI E; AGOSTINELLI C; PICCALUGA PP; ZINZANI P.; PILERI SA | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | EIM07.full.pdf |
Identification of outcome predictors in diffuse large B-cell lymphoma. of homogeneously treated de novo nodal tumours on tissue micro-arrays. | Pileri S.A.; Dirnhofer S.; Sabattini E.; Piccaluga P.P.; Bacci F.; Agostinelli C.; Bodega L.; Ord...uz R.; Falini B.; Zinzani P.L. | 2004-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation. | PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BIANCHINI M; VIGNA E; BOSI C; GAITANI S; VISAN...I G; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Babesia infection in Italy | PICCALUGA PP; POLETTI G; MARTINELLI G.; GHERLINZONI F | 2004-01-01 | THE LANCET INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | - |
Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. | Mele A; Sparaventi G; Guiducci B; Nicolini G; d'Adamo F; Leopardi G; Delfini C; Piccaluga P; Visa...ni G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients. | PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M....; MARTINELLI G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients. | PICCALUGA PP; MARTINELLI G; RONDONI M; MALAGOLA M; GAITANI S; VISANI G; BACCARANI M. | 2004-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia | PICCALUGA PP; LUATTI S; ASCANI S; BIANCHINI M; MALAGOLA M; RONDONI M; GAITANI S; TESTONI N.; PILE...RI SA; BACCARANI M; MARTINELLI G; VISANI G | 2004-01-01 | CANCER GENETICS AND CYTOGENETICS | - | 1.01 Articolo in rivista | - |
Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly | Piccaluga, Pier Paolo; Martinelli, Giovanni; Rondoni, Michela; Malagola, Michele; Ronconi, Sonia;... Visani, Giuseppe; Baccarani, Michele | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | ECR37.full.pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile